Literature DB >> 16501922

[Cutaneous lupus erythematosus. Part 1: clinical manifestations and classification].

A Kuhn1, K Gensch, S Ständer, G Bonsmann.   

Abstract

Cutaneous lupus erythematosus (CLE) is a heterogenous disorder with a wide range of skin manifestations. Therefore, it has been difficult to develop a unifying concept for classifying CLE from the dermatologic perspective in the past. In 2004, the classification system was updated and includes now acute CLE (ACLE), subacute CLE (SCLE), chronic CLE (CCLE), and intermittent CLE (ICLE). Additional rarely described variants are not listed as separate entities but are included in the classical forms. Diagnosis of the different subtypes of CLE is made by considering genetic, clinical, histopathologic, and immunoserologic findings, with a systematic analysis of individual criteria. In the past years, the etiology and pathogenesis of CLE has been subject of intensive research and it has been shown by several groups that exogenous factors, such as ultraviolet light and drugs, can induce CLE. The first part of this review will enable the reader to identify the various clinical manifestations of CLE and to employ characteristic criteria to assess differential diagnostic considerations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501922     DOI: 10.1007/s00105-006-1094-y

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  60 in total

1.  Phototesting in lupus erythematosus: a 15-year experience.

Authors:  A Kuhn; M Sonntag; D Richter-Hintz; C Oslislo; M Megahed; T Ruzicka; P Lehmann
Journal:  J Am Acad Dermatol       Date:  2001-07       Impact factor: 11.527

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 3.  Pathology, immunopathology, and immunohistochemistry in cutaneous lupus erythematosus.

Authors:  K M David-Bajar; B M Davis
Journal:  Lupus       Date:  1997       Impact factor: 2.911

4.  Distinctive cutaneous subsets in the spectrum of lupus erythematosus.

Authors:  J N Gilliam; R D Sontheimer
Journal:  J Am Acad Dermatol       Date:  1981-04       Impact factor: 11.527

5.  Chilblain lupus erythematosus: report of 15 cases.

Authors:  M S Doutre; C Beylot; J Beylot; E Pompougnac; P Royer
Journal:  Dermatology       Date:  1992       Impact factor: 5.366

6.  Terbinafine-induced subacute cutaneous lupus erythematosus.

Authors:  G Bonsmann; M Schiller; T A Luger; S Ständer
Journal:  J Am Acad Dermatol       Date:  2001-06       Impact factor: 11.527

Review 7.  Discoid lupus erythematosus (DLE)-like lesion induced by uracil-tegafur (UFT).

Authors:  T Yoshimasu; A Hiroi; K Uede; F Furukawa
Journal:  Eur J Dermatol       Date:  2001 Jan-Feb       Impact factor: 3.328

Review 8.  Cutaneous lupus erythematosus: a review.

Authors:  Purvisha Patel; Victoria Werth
Journal:  Dermatol Clin       Date:  2002-07       Impact factor: 3.478

Review 9.  Cutaneous lupus erythematosus: diagnosis and management.

Authors:  Paolo Fabbri; Carla Cardinali; Barbara Giomi; Marzia Caproni
Journal:  Am J Clin Dermatol       Date:  2003       Impact factor: 7.403

10.  Clinical, serologic and immunogenetic studies in patients with chronic cutaneous (discoid) lupus erythematosus who have verrucous and/or hypertrophic skin lesions.

Authors:  C R Spann; J P Callen; J B Klein; K B Kulick
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

View more
  3 in total

1.  [Drug-induced subacute cutaneous lupus erythematosus: repeated occurrence following treatment with terbinafine].

Authors:  G Wagner; M M Sachse
Journal:  Hautarzt       Date:  2014-06       Impact factor: 0.751

2.  Clinical characteristics of cutaneous lupus erythematosus.

Authors:  Justyna Szczęch; Maja Rutka; Dominik Samotij; Agnieszka Zalewska; Adam Reich
Journal:  Postepy Dermatol Alergol       Date:  2016-02-29       Impact factor: 1.837

3.  Spirituality and mood pathology in severe skin conditions: a prospective observational study.

Authors:  Human-Friedrich Unterrainer; M Lukanz; M Pilch; S Scharf; M Glawischnig-Goschnik; N Wutte; R Fink-Puches; E Aberer
Journal:  Arch Dermatol Res       Date:  2016-07-04       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.